You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

ZINC SULFATE - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for zinc sulfate and what is the scope of patent protection?

Zinc sulfate is the generic ingredient in one branded drug marketed by Abraxis Pharm, Am Regent, Fresenius Kabi Usa, Gland Pharma Ltd, and Zydus Pharms, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for zinc sulfate. Six suppliers are listed for this compound.

Summary for ZINC SULFATE

US Patents:	0
Tradenames:	1
Applicants:	5
NDAs:	5
Drug Master File Entries:	1
Finished Product Suppliers / Packagers:	6
Raw Ingredient (Bulk) Api Vendors:	48
Clinical Trials:	1,055
Patent Applications:	3,727
Formulation / Manufacturing:	see details
Drug Sales Revenues:	Drug sales revenues for ZINC SULFATE
What excipients (inactive ingredients) are in ZINC SULFATE?	ZINC SULFATE excipients list
DailyMed Link:	ZINC SULFATE at DailyMed

Drug Sales Revenue Trends for ZINC SULFATE

See drug sales revenues for ZINC SULFATE

Recent Clinical Trials for ZINC SULFATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Wake Forest University Health Sciences	Phase 3
Cukurova University	Phase 4
Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Limited	Phase 1

See all ZINC SULFATE clinical trials

Pharmacology for ZINC SULFATE

Drug Class	Copper Absorption Inhibitor
Physiological Effect	Decreased Copper Ion Absorption

Medical Subject Heading (MeSH) Categories for ZINC SULFATE

Astringents

US Patents and Regulatory Information for ZINC SULFATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Pharms	ZINC SULFATE	zinc sulfate	SOLUTION;INTRAVENOUS	217074-003	Aug 22, 2023	AP	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Fresenius Kabi Usa	ZINC SULFATE	zinc sulfate	SOLUTION;INTRAVENOUS	216145-001	Dec 27, 2022	AP	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Zydus Pharms	ZINC SULFATE	zinc sulfate	SOLUTION;INTRAVENOUS	217074-001	Aug 22, 2023	AP	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.